We are live on ! Find out more
JRP

Jasper Ridge Partners Portfolio holdings

AUM $4.49B
1-Year Est. Return 18.72%
This Fund
S&P 500
This Quarter Est. Return
+12.83%
1 Year Est. Return
+18.72%
3 Year Est. Return
+61.54%
5 Year Est. Return
+51.38%
10 Year Est. Return
+238.82%
AUM
$2.35B
AUM Growth
+$719M
Cap. Flow
+$507M
Cap. Flow %
21.57%
Top 10 Hldgs %
91.68%
Holding
92
New
20
Increased
12
Reduced
5
Closed
4

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$270M
2
IWD icon
iShares Russell 1000 Value ETF
IWD
+$176M
3
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$143M
4
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$25.7M
5
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$19.2M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$64.6M
2
TSLA icon
Tesla
TSLA
+$47.9M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$38.8M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$23.8M
5
DNLI icon
Denali Therapeutics
DNLI
+$5.81M

Sector Composition

Rank Sector Weight
1 Technology 3.28%
2 Communication Services 2.19%
3 Consumer Discretionary 1.09%
4 Financials 0.76%
5 Healthcare 0.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASXC
76
DELISTED
Asensus Surgical, Inc.
ASXC
$297K 0.01%
9,586
– –
FOXA icon
77
Fox Class A
FOXA
$24.1B
$259K 0.01%
+7,067
New +$275K
CRCM
78
DELISTED
CARE.COM, INC.
CRCM
$259K 0.01%
13,115
– –
QCOM icon
79
Qualcomm
QCOM
$180B
$251K 0.01%
4,400
– –
ZLAB icon
80
Zai Lab
ZLAB
$2.32B
$237K 0.01%
+8,024
New +$220K
AIMT
81
DELISTED
Aimmune Therapeutics
AIMT
$232K 0.01%
10,385
– –
GOOGL icon
82
Alphabet (Google) Class A
GOOGL
$4.3T
$218K 0.01%
3,700
-1,144,860
-100% -$64.6M
IPHI
83
DELISTED
INPHI CORPORATION
IPHI
$215K 0.01%
+4,924
New +$196K
IMMU
84
DELISTED
Immunomedics Inc
IMMU
$210K 0.01%
10,924
– –
SENS icon
85
Senseonics Holdings Inc
SENS
$267M
$148K 0.01%
3,019
– –
SONO icon
86
Sonos
SONO
$1.81B
$132K 0.01%
+12,817
New +$139K
HIVE
87
DELISTED
Aerohive Networks
HIVE
$98K ﹤0.01%
21,532
– –
METC icon
88
Ramaco Resources Class A
METC
$747M
$96K ﹤0.01%
+17,081
New +$93K
DNLI icon
89
Denali Therapeutics
DNLI
$3.63B
– –
-281,250
Closed -$5.81M
LOXO
90
DELISTED
Loxo Oncology, Inc
LOXO
– –
-3,457
Closed -$484K
WRD
91
DELISTED
WildHorse Resource Development
WRD
– –
-27,095
Closed -$382K
TSRO
92
DELISTED
TESARO, Inc.
TSRO
– –
-4,028
Closed -$299K
1 2 3
4

Similar funds

CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
TI
Truepoint Inc Cincinnati, Ohio $4.48B AUM 13.76% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return
DK
DJE Kapital 82049 Pullach, Germany $4.51B AUM 49.55% 1-Year Est. Return
GIBU
Gulf International Bank (UK) London, United Kingdom $4.47B AUM 29.35% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
BAAM
Baker Avenue Asset Management San Francisco, California $4.43B AUM 26.6% 1-Year Est. Return
CAU
Caxton Associates (UK) London $4.42B AUM 49.83% 1-Year Est. Return

Jasper Ridge Partners's Q1 2019 Portfolio in Review

As of Q1 2019, Jasper Ridge Partners held 92 positions worth $2.35B, up 44% from $1.63B the previous quarter. Its ten largest holdings account for 92% of the portfolio.

Jasper Ridge Partners deployed $507M of net new capital in Q1 2019, opening 20 new positions and adding to 12 existing holdings. Its largest new stake was Berkshire Hathaway Class B: 30,450 shares worth $6.12M.

By sector, the portfolio is most concentrated in Technology at 3.3% of assets, up from 2.7% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $64.6M trimmed.

  • Jasper Ridge Partners's largest Q1 2019 buy was Berkshire Hathaway Class B: 30,450 shares worth $6.12M.
  • Jasper Ridge Partners added most to iShares Core S&P 500 ETF in Q1 2019, an estimated $270M increase.
  • Jasper Ridge Partners's biggest Q1 2019 reduction was Alphabet (Google) Class A, cutting an estimated $64.6M.
  • Jasper Ridge Partners fully exited Denali Therapeutics in Q1 2019, selling an estimated $5.81M.
  • Jasper Ridge Partners's ten largest holdings make up 92% of its $2.35B portfolio in Q1 2019.
  • Jasper Ridge Partners opened 20 new positions and closed 4 in Q1 2019.
  • Jasper Ridge Partners's portfolio value rose 44% quarter-over-quarter to $2.35B.

Based on Jasper Ridge Partners's 13F filing for Q1 2019, filed 13 May 2019.